Singapore markets close in 1 hour 3 minutes

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
62.00+0.40 (+0.65%)
At close: 04:00PM EDT
62.00 0.00 (0.00%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close61.60
Open61.58
Bid0.00 x 4000
Ask0.00 x 1300
Day's range61.38 - 62.05
52-week range57.17 - 74.12
Volume5,153,412
Avg. volume7,094,440
Market cap77.767B
Beta (5Y monthly)0.35
PE ratio (TTM)18.96
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.92 (4.74%)
Ex-dividend date14 Sept 2022
1y target estN/A
  • Business Wire

    Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobilize to Address Monkeypox Public Health Emergency

    FOSTER CITY, Calif., August 09, 2022--Gilead Sciences, Inc. (Nasdaq: GILD), GLAAD, the Human Rights Campaign (HRC), the National Black Justice Coalition (NBJC), the National Center for Lesbian Rights (NCLR) and NMAC today announced immediate action in response to the emerging monkeypox virus (MPV) outbreak, which is disproportionately impacting the LGBTQ+ community, particularly men who have sex with men (MSM), as well as those who are living with HIV. Gilead will provide up to $5 million in glo

  • Business Wire

    Gilead Sciences to Acquire MiroBio

    FOSTER CITY, Calif. & OXFORD, England, August 04, 2022--Gilead Sciences, Inc. (Nasdaq: GILD) and MiroBio, a privately-held U.K.-based biotechnology company focused on restoring immune balance with agonists targeting immune inhibitory receptors, today announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire MiroBio for approximately $405 million in cash, subject to customary adjustments.

  • Business Wire

    Gilead Sciences Announces Second Quarter 2022 Financial Results

    FOSTER CITY, Calif., August 02, 2022--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the second quarter of 2022.